newsfilter
← Latest News
GlobeNewswire·

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

LONDON, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it